MarketScreener Strategies Intellia Therapeutics, Inc.
Equities
NTLA
US45826J1051
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.95 USD | +5.58% |
|
+10.82% | +66.30% |
| Mar. 06 | Nektar Therapeutics reports inducement grants under Nasdaq Listing Rule 5635(c)(4) | RE |
| Mar. 03 | Intellia Therapeutics Presents Longer-Term Clinical Data For Lonvoguran Ziclumeran | CI |
MarketScreener Strategies
Search
No results for this search
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
